PCOS and Low Sex Drive: What the Research Actually Found

PCOS and Low Sex Drive: What the Research Actually Found

If you have PCOS and no sex drive, the honest answer from the research is mixed, and the mixed answer is more useful than the confident one you keep reading. Four large reviews have looked. They agree that women with PCOS report more depression, more anxiety, lower quality of life, and lower sexual satisfaction. They disagree about whether overall sexual function scores differ at all, and the biggest review graded its own certainty as low on every result it published. Nobody has shown that PCOS reaches into your hormones and switches desire off. The effect travels a longer route, through mood and how you feel in your body.

Key takeaways
  • The 2024 review behind the 2023 International PCOS Guidelines found worse sexual function overall (Hedges' g -0.75, 95% CI -1.37 to -0.12) with 98% heterogeneity between studies, and rated the certainty of every outcome it published as low.
  • Across 46 studies and 30,989 participants, depression ran higher in PCOS (SMD 0.64, 95% CI 0.50 to 0.78), anxiety higher (0.63, 0.50 to 0.77), quality of life lower (-0.55, -0.69 to -0.40), and sexual dysfunction was not statistically significant (-0.24, 95% CI -0.49 to 0.01).
  • Sexual satisfaction on a visual analogue scale was much lower across 36 studies (mean difference -29.67, 95% CI -36.97 to -22.37), while total sexual function score in that review showed no difference (-0.06, 95% CI -0.51 to 0.38). The odds of obstructive sleep apnea in the same review came out at 10.81, on an interval running from 2.39 to 48.83.
  • No study in this literature has measured sexual distress in PCOS, the missing half of what a clinician needs before calling anything a dysfunction.
0.64
pooled standardized difference in depression scores, women with PCOS against women without, across 28 studies, 95% CI 0.50 to 0.78. Self-reported, and varied widely by country.
35% / 29.6%
prevalence of female sexual dysfunction with PCOS against without, pooled from 28 observational studies. Total scores in those same women were 24.59 against 26.04, p = 0.237.
Low
the GRADE certainty rating the 2024 guideline review gave every sexual function outcome it published, including the ones that reached significance.

Figures from Yin et al. 2021 (PMID 32514730), Loh et al. 2020 (PMID 32462512), and Pastoor et al. 2024 (PMID 38237144).

Is this normal, or is it the PCOS?

PCOS is a diagnosable endocrine condition, and a doctor makes that call using criteria involving irregular cycles, raised androgens, and ovarian appearance on ultrasound. If your desire has flattened since the diagnosis, you are asking a reasonable question that the internet answers badly. Search "does PCOS cause low libido" and you get a confident yes, usually attached to a supplement or a protocol. The research does not support that yes.

This is the same shape of question we walked through in the thyroid and low libido connection. A diagnosis arrives, it explains some of what you are feeling, and then people stretch it to explain everything. The stretch is where the harm happens, because once you have decided the condition explains your whole experience, you stop looking at the parts that respond to attention. Endometriosis follows the same pattern, and we went through it in endometriosis and low sex drive.

A diagnosis gives you a name for a cluster of things happening in your body. It does not hand you a mechanism for every symptom you have, and PCOS and low libido is a case where the mechanism has never been demonstrated. Four reviews looked, and none produced a clean line from the endocrine condition to desire. They mapped the places the effect seems to travel through: mood, quality of life, how you feel about your own body, and sleep. Our piece on why your libido is so low covers the wider set of drivers.

What the four big reviews actually found

Four systematic reviews cover this ground. Together they pool tens of thousands of women. Apart, they contradict each other on the headline question.

The largest and most recent is Pastoor and colleagues, published in Human Reproduction Update in 2024 to inform the 2023 International Guidelines for the Assessment and Management of PCOS. Across its 32 articles, overall sexual function came out worse in women with PCOS, at a Hedges' g of -0.75 with a 95% confidence interval from -1.37 to -0.12, an interval that barely clears zero at one end. Heterogeneity was 98%, meaning the studies pointed in wildly different directions and the pooled number averages across genuine disagreement. Sexual satisfaction was steadier at -0.31, 95% CI -0.45 to -0.18, heterogeneity 68%. The authors ran GRADE assessments and reported low certainty across all outcomes. That rating is theirs, in their own abstract.

Loh and colleagues pooled 28 observational studies covering 6,256 women. Female sexual dysfunction turned up in 35% of women with PCOS and 29.6% of women without, giving odds of 1.32 (95% CI 1.07 to 1.61). The same review then compared total sexual function scores and found 24.59 against 26.04, p = 0.237, which in statistical terms is no difference at all.

Yin and colleagues, across 46 studies and 30,989 participants, found depression, anxiety, and quality of life all moved clearly while sexual dysfunction did not reach statistical significance at -0.24 (95% CI -0.49 to 0.01). Thannickal and colleagues, across 36 studies and 349,529 patients, found sexual satisfaction much lower on a visual analogue scale at -29.67 (95% CI -36.97 to -22.37) and total sexual function score at -0.06 (95% CI -0.51 to 0.38), straddling zero comfortably.

Three of the four reviews that measured a total score found no significant difference, while satisfaction measures and prevalence counts did move.

Where the PCOS evidence is solid and where it falls apart.
Outcome The number, with its interval Well supported, or disputed
Depression, anxiety, quality of life SMD 0.64 (95% CI 0.50 to 0.78) from 28 studies; 0.63 (0.50 to 0.77) from 22; and -0.55 (-0.69 to -0.40) from 16 Well supported. Tight intervals, consistent direction, all self-reported
Sexual satisfaction Hedges' g -0.31, 95% CI -0.45 to -0.18; on a visual analogue scale, mean difference -29.67, 95% CI -36.97 to -22.37 Direction supported by two reviews. Certainty graded low by the authors of the first
Obstructive sleep apnea Odds ratio 10.81, 95% CI 2.39 to 48.83 Direction supported, size wide open. An interval spanning a factor of twenty is a signal and no more
Total sexual function score -0.75 (95% CI -1.37 to -0.12, heterogeneity 98%); 24.59 against 26.04, p = 0.237; -0.06 (95% CI -0.51 to 0.38); -0.24 (95% CI -0.49 to 0.01) Disputed. Three of the four found no significant difference
A direct hormonal route from PCOS to desire No pooled estimate exists. The 2024 guideline review states that no included study assessed sexual distress Not established. Anyone claiming it is has gone past the evidence

Where the evidence is strong: mood and quality of life

The steadiest findings in this literature are about how living with PCOS feels. Yin's review pooled 46 studies covering 30,989 participants, 9,265 with PCOS and 25,638 without. Twenty-eight of those studies measured depression, 22 anxiety, 16 quality of life, and 12 sexual dysfunction. The mood and life-quality results all landed clearly, and the sexual dysfunction result did not.

Four outcomes from one review, on the same scale

Standardized mean differences from Yin et al. 2021, women with PCOS against controls. Dots are the pooled estimate, bars the 95% confidence interval. A bar crossing the zero line means the result did not reach statistical significance.

Standardized effects in PCOS from Yin et al. 2021 Depression 0.64, interval 0.50 to 0.78. Anxiety 0.63, interval 0.50 to 0.77. Quality of life minus 0.55, interval minus 0.69 to minus 0.40. Sexual dysfunction minus 0.24, interval minus 0.49 to 0.01, crossing zero and not statistically significant. no difference -0.75 -0.50 -0.25 0 0.25 0.50 0.75 standardized mean difference Depression 28 studies 0.64 Anxiety 22 studies 0.63 Quality of life 16 studies -0.55 Sexual dysfunction 12 studies -0.24 NOT SIGNIFICANT, interval crosses zero

Source: Yin X, Ji Y, Chan CLW, Chan CHY, Archives of Women's Mental Health 2021 (PMID 32514730). Random-effects models across 46 studies and 30,989 participants. The reviewers noted heterogeneous results across countries, criteria, and instruments.

The two mood bars sit well clear of the zero line with short intervals, which is what a consistent finding looks like. The quality of life bar does the same in the other direction. The sexual dysfunction bar is drawn open and dashed because its interval runs from -0.49 up to 0.01, so a true effect of zero stays entirely compatible with the data.

Depression and anxiety are among the strongest known suppressors of desire in women, and they are the results with the tightest intervals in the whole PCOS literature. So there is a plausible, well-evidenced route from PCOS to a flat sex drive, and it runs through mood. We cover that route on its own terms in depression and low libido.

"I feel SO broken as a woman"

This sentence turns up constantly in PCOS forums, and there is research underneath it.

Pastoor and colleagues ran a separate analysis on the four studies that used visual analogue scales, which ask women to mark how they feel on a line, and it produced the most human result in the paper. Compared with controls, women with PCOS reported a negative impact of excess body hair on their sexuality, lower sexual attractiveness, and lower sexual satisfaction. How important a satisfying sex life was to them did not differ. The wanting is intact. She feels differently about being seen.

Loh's review puts a number on the physical side. Women with PCOS in those 28 studies had a mean Ferriman-Gallwey score of 10.0 against 4.0, the standard clinical scoring of excess body hair, and mean serum total testosterone of 2.34 nmol/L against 1.57. Those are group averages across studies using different diagnostic criteria, so no individual woman should read her own experience off them.

Feeling unattractive is a state, and it moves with how you are treated and what you say to yourself. Our piece on body confidence as the internal barrier to libido covers how that works and what shifts it.

The 2024 reviewers named a gap themselves. No study in their review measured sexual distress. Distress is the piece a clinician needs before calling anything a dysfunction, since a low questionnaire score in a woman untroubled by it is a different situation from the same score in a woman grieving it. The literature has not asked.

The sleep apnea finding nobody mentions

Thannickal and colleagues pooled 36 studies covering 349,529 patients, looking at eating, sleep, and sexual function alongside PCOS. The sleep results should have travelled further than they did.

Women with PCOS were more likely to have obstructive sleep apnea, at an odds ratio of 10.81, with a 95% confidence interval from 2.39 to 48.83. Hypersomnia came in at 4.39, interval 1.07 to 18.07. Both intervals are enormous. An interval spanning from "twice as likely" to "nearly fifty times as likely" tells you the association is real and the magnitude is unresolved. Anyone quoting 10.81 as a settled figure is quoting the midpoint of a very wide guess.

Sleep apnea fragments your night without you knowing it happened. You wake unrefreshed, drag through the day, and the tiredness gets attributed to the hormonal condition because that is the label already in the room. Untreated apnea also carries daytime sleepiness and low mood, both upstream of desire.

So if you have PCOS and you snore, wake unrefreshed after enough hours in bed, or feel sleepy during the day, ask your doctor about a sleep study. Treated apnea changes how people feel in a way very little else does. We go deeper on that link in sleep apnea and low libido.

"The numbers were fine and I still feel flat"

Three of the four reviews here found no statistically significant difference in total sexual function score between women with and without PCOS. If you have PCOS and a flat sex drive, that finding can land as a slap. It reads like being told nothing is happening.

A total score is one number averaged out of several separate questionnaire sections, and averaging is very good at hiding movement. When one part of a score drops and another holds steady, the total can sit still while a woman's experience has changed a lot. In Loh's review the total score was no different at p = 0.237, while prevalence of dysfunction was higher, 35% against 29.6%, odds 1.32.

Low desire is also common in women generally, with or without a diagnosis. Worsley and colleagues surveyed a nationally representative community sample of 2,020 Australian women aged 40 to 65 using validated instruments. Low desire turned up in 69.3%, sexually related personal distress in 40.5%, and the two together, meeting criteria for hypoactive sexual desire dysfunction, in 32.2%. That study had nothing to do with PCOS. It is a baseline, and the baseline is high. In their adjusted model, moderate to severe depressive symptoms carried odds of 2.69 for that diagnosis, the mood route showing up again in a completely different dataset.

So when the numbers come back fine and you still feel flat, the number was never the thing to argue with. We wrote about that experience in normal labs, low libido.

What a PCOS diagnosis does and does not explain

One diagnosis, two very different columns

What it does explain
  • A higher load of depression and anxiety symptoms, pooled across dozens of studies with tight intervals
  • Lower health-related quality of life, at -0.55 across 16 studies
  • Distress about excess body hair and feeling less attractive, from the visual analogue scale studies
  • A raised chance of sleep apnea and hypersomnia, size still unresolved
  • Lower reported sexual satisfaction, in two independent reviews
What it does not explain
  • A direct hormonal switch that lowers desire. No review has demonstrated one
  • Your total sexual function score. Three of four reviews found no significant difference there
  • How distressed you are by any of it. No study in the 2024 review measured sexual distress
  • Everything else that flattens desire: medication, sleep debt, a strained relationship, exhaustion, stress
  • Why one woman with PCOS feels no change and another a large one. Heterogeneity of 98% on the pooled total score is the statistical version of that variation

Left column from PMID 32514730, PMID 38237144, and PMID 31917860. Right column is what those same papers report as absent, non-significant, or unmeasured. The 2024 review graded certainty as low across all of its sexual function outcomes.

"Brain fog, no energy, no drive": what to take to your doctor

A research summary is a poor substitute for being examined by someone who knows your history. The research gives you a better set of questions, so the appointment covers ground it might otherwise skip.

  1. Ask about mood first, and ask plainly. Depression and anxiety are the findings with the strongest support in the entire PCOS literature, and both are treatable. If the last few months have been heavy, say so out loud, even if you came in to talk about sex drive.
  2. Ask about sleep, specifically apnea. Snoring, waking unrefreshed, daytime sleepiness, or a partner who has noticed you stop breathing all justify a referral for a sleep study.
  3. Bring your full medication list, including hormonal contraception and anything for mood. Several common medicines lower desire, and that is easy to miss when a diagnosis is already on the table.
  4. Ask what your PCOS care plan targets. Cycles, metabolic markers, and excess hair growth are separate goals, and knowing which one is being addressed tells you what to stop waiting for.
  5. Say the quiet part. If you feel unattractive, or broken, or ashamed, that belongs in the appointment. The visual analogue scale research found precisely this cluster, so it is documented and reasonable to raise.

Bring the evidence if it helps. A clinician reading that the 2024 guideline review found low certainty across all outcomes knows the literature has not settled, so your individual picture carries more weight than any average.

The everyday levers, and where a botanical fits

Separate from anything clinical, a few things move desire in most people, and the free ones do more work than the internet admits.

  • Sleep, in quantity and quality. If apnea is in play, treating it belongs to your doctor. Plain sleep debt is yours to reclaim, and it is free.
  • Care for your mood, taken seriously. Therapy, medication where a doctor thinks it fits, and the ordinary supports of a life not permanently under strain.
  • Time and safety with a partner, or on your own. Desire responds to a nervous system that is not braced.
  • Movement and food you enjoy, aimed at feeling well in your body. Aimed at punishment, it backfires.
  • A botanical supplement, if you want one, as the smallest lever on the list.

NUUD is a botanical supplement built around desire in general. It has nothing to do with PCOS, does nothing to your hormones, and is no part of managing an endocrine condition. The formula is anchored by the NUUD Mushroom Complex, with Muira Puama, Boiled Rehmannia Root, Tribulus Terrestris, and Piper Nigrum for absorption, on a timeline of roughly 30 to 60 minutes. If the everyday levers are in decent shape and you want one more, that is what our women's libido support capsules are for. If sleep is broken or your mood is on the floor, start there and let the capsule wait.

Supporting hormones through diet and lifestyle is a separate question with its own guide in natural ways to balance hormones for female libido. This article stays on what a PCOS diagnosis does and does not tell you.

Nothing is wrong with you

You have probably been handed two unhelpful answers already. One is a shrug from a doctor who had eight minutes. The other is a confident internet voice with a protocol to sell, telling you PCOS wrecked your libido and here is the fix.

The research supports neither. It says women with PCOS carry more depression, more anxiety, lower quality of life, more distress about their appearance, more sleep apnea, and lower sexual satisfaction, and it says the direct link to desire has never been shown. Every one of those first items has a real name, and most respond to attention. That is a better starting position than a hormonal verdict you can do nothing about.

You have a diagnosis. Your desire has a context, and the relationship between them is looser and more workable than anyone selling you something wants to admit.

Keep reading

Frequently asked questions

Does PCOS cause low libido?
No study has shown that it does, and four large reviews have looked. The 2024 review that informed the 2023 International PCOS Guidelines found worse overall sexual function in women with PCOS, with a Hedges' g of -0.75 and a 95% confidence interval of -1.37 to -0.12, heterogeneity of 98% between studies, and the authors graded the certainty of every outcome as low. Three other reviews found no statistically significant difference in total sexual function score. The evidence does support an association with depression, anxiety, lower quality of life, distress about excess body hair, and a higher chance of obstructive sleep apnea, all of which can lower desire on their own.

Why do I have PCOS and no sex drive when my labs look fine?
Because a lab panel and a sex drive measure different things. Loh and colleagues pooled 28 studies covering 6,256 women and found female sexual dysfunction in 35% of women with PCOS against 29.6% without, odds ratio 1.32 with a 95% confidence interval of 1.07 to 1.61, while total sexual function scores in the same women came out at 24.59 against 26.04, p = 0.237. Desire is shaped by mood, sleep, medication, how safe you feel with a partner, and how you feel in your own body, and none of those appear on a hormone panel. Talk to your doctor about screening for depression and for sleep apnea before assuming your bloodwork holds the answer.

Is low sex drive with PCOS normal?
It is common, and it is common in women without PCOS too. In a nationally representative community sample of 2,020 Australian women aged 40 to 65, low desire measured on a validated instrument turned up in 69.3%, sexually related personal distress in 40.5%, and both together in 32.2%. That study included no PCOS selection at all. A flat sex drive is a widespread experience with many contributors, and having PCOS puts a name in the room that can crowd out the other explanations worth checking.

Can treating my PCOS bring my sex drive back?
Nobody can promise that, because the evidence for a direct link between PCOS and desire is low certainty at best. The 2024 guideline review graded all of its sexual function outcomes as low certainty and reported that no included study measured sexual distress. The evidence supports treating what travels with PCOS: depression higher across 28 studies at a standardized mean difference of 0.64, anxiety at 0.63 across 22 studies, and odds of obstructive sleep apnea of 10.81 on a very wide 95% confidence interval of 2.39 to 48.83. Each is treatable, and each is associated with low desire in its own right.

I just want to feel normal again. Where do I start?
Start with mood and sleep, because those carry the strongest evidence in the PCOS literature and both respond to treatment. Ask your doctor about depression and anxiety screening, and about a sleep study if you snore or wake unrefreshed. Review your medication list, since several common medicines lower desire. Then look at the ordinary levers: rest, time that is not rushed, and being in your body without judging it. Nothing is wrong with you for having landed here. Women with PCOS carry a heavier load of depression, anxiety, and lower quality of life, and a flat sex drive sitting on top of that load is an understandable response to it.

References

  1. Pastoor H, Mousa A, Bolt H, et al. Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update. 2024;30(3):323-340. https://pubmed.ncbi.nlm.nih.gov/38237144/
  2. Loh HH, Yee A, Loh HS, Kanagasundram S, Francis B, Lim LL. Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones (Athens). 2020;19(3):413-423. https://pubmed.ncbi.nlm.nih.gov/32462512/
  3. Yin X, Ji Y, Chan CLW, Chan CHY. The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis. Archives of Women's Mental Health. 2021;24(1):11-27. https://pubmed.ncbi.nlm.nih.gov/32514730/
  4. Thannickal A, Brutocao C, Alsawas M, et al. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Clinical Endocrinology (Oxf). 2020;92(4):338-349. https://pubmed.ncbi.nlm.nih.gov/31917860/
  5. Worsley R, Bell RJ, Gartoulla P, Davis SR. Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women. The Journal of Sexual Medicine. 2017;14(5):675-686. https://pubmed.ncbi.nlm.nih.gov/28499520/

This article is for general education and is not medical advice. PCOS is a medical condition that only a licensed clinician can diagnose and manage. NUUD is a botanical supplement and has no role in diagnosing, treating, curing, or preventing PCOS or any other disease, and these statements have not been evaluated by the Food and Drug Administration. Talk with your doctor about diagnosis, about mood and sleep symptoms, and about any medication before starting a new supplement.

Back to blog